hig.sePublikasjoner
Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • harvard-cite-them-right
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • sv-SE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • de-DE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Evaluatin Strategy for Candidates drug and implementation to product D: MBA-thesis in marketing
Högskolan i Gävle, Institutionen för ekonomi.
2008 (engelsk)Independent thesis Advanced level (degree of Magister), 10 poäng / 15 hpOppgave
Abstract [en]

Biovitrumis is one of the larger biopharma companies in Euprope and conducts research in different niche areas. One of the interested areas for Biovitrum is Exocrine Pancreatic insufficiency. Biovitrum has a candidate drug (product D) in early development process for treatment of. Exocrine Pancreatic Insufficiency.

The Drug development is a long, complicated and costly process. Therefore, it is very important for managers to know the commercial value of a future drug. The purpose of this report is to develop a model for evaluation of candidate drug in early development phase and analysis of market potential for product D for treatment of Chronic pancreatitis. Chronic pancreatitis is disease within sub group of Exocrine Pancreatic Insufficiency.

The deductive reasoning approach and quantitative data is used in this report. Only secondary data is collected for this study. The sources of secondary data are research papers, Google Pub-Med database and consultant companies.

A new model is developed for evaluation of candidate drug .This model can analyse the market potential, unmet medical need, and calculate net present values. This study shows that there is unmet medical need in chronic pancreatitis. The result also shows that product D has comparative advantages over present products in the market and future competitors. The product D can full fill the unmet medical need for treatment of Chronic pancreatitis

sted, utgiver, år, opplag, sider
2008. , s. 45
Emneord [en]
Candidate Drug, Evaluation strategy, market analysis
HSV kategori
Identifikatorer
URN: urn:nbn:se:hig:diva-694Arkivnummer: E3BA: DiVA 082/08OAI: oai:DiVA.org:hig-694DiVA, id: diva2:120278
Uppsök
samhälle/juridik
Veileder
Examiner
Tilgjengelig fra: 2008-09-16 Laget: 2008-09-16

Open Access i DiVA

fulltekst(896 kB)1240 nedlastinger
Filinformasjon
Fil FULLTEXT01.pdfFilstørrelse 896 kBChecksum MD5
f03612459bc7c76905232ef3e2c494b22e33f097325e17bad25986558ed093b74d9b3bb4
Type fulltextMimetype application/pdf

Av organisasjonen

Søk utenfor DiVA

GoogleGoogle Scholar
Totalt: 1240 nedlastinger
Antall nedlastinger er summen av alle nedlastinger av alle fulltekster. Det kan for eksempel være tidligere versjoner som er ikke lenger tilgjengelige

urn-nbn

Altmetric

urn-nbn
Totalt: 667 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • harvard-cite-them-right
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • sv-SE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • de-DE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf